Gentler cervical screening tool tested, but study cut short
NCT ID NCT04000477
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two devices used to collect tissue from the cervix during screening for cervical cancer: the standard Kevorkian curette and a softer cytobrush. The goal was to see if the cytobrush causes less pain while still getting enough cells for diagnosis. Only 3 women were enrolled before the study was stopped, so no firm conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cytobrush and Kevorkian curette (medical devices)
- What this could lead to
- If the cytobrush works as well as the curette but causes less pain, it could become a more comfortable option for cervical screening procedures.
- What could go wrong
- The trial was terminated early with only 3 participants, so results are very limited and may not be reliable. The cytobrush might also fail to collect enough tissue for diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Nov 2019
- Finished
-
Nov 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women followed for a cervical pathology requiring endocervical curettage: * AGC type (glandular cell atypia) with positive HPV test * Frottis ASC-H, LSIL, ASCUS HPV + with non-contributive colposcopy (ZT3) Exclusion Criteria: * Pregnant woman * Women under the age of 25 or over 65 * Stenosis of the neck complete or tight not allowing the possible insertion of a curette (inadequate size cervical orifice and material) * Presence of a vaginal lesion on colposcopic examination
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de gynécologie endocrinienne et médecine de la reproduction
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsed radiation extend life in metastatic cervical cancer?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Smart speculum could bring cervical cancer screening to remote areas
- Your gut bacteria may hold the key to whether immunotherapy works
- Amazon plant put to the test against Cancer's relentless tiredness